Navigation Links
PharmAthene Reports Year-End 2009 Financial and Operational Results and Provides Update On Ongoing Litigation With SIGA Technologies
Date:3/23/2010

925,489 Other long-term assets and deferred costs 308,973 257,623 Goodwill 2,348,453 2,502,909 --------- --------- Total assets $34,065,014 $56,391,270 =========== =========== LIABILITIES AND STOCKHOLDERS' EQUITY ------------------------------------ Current liabilities: Accounts payable $1,934,119 $3,870,871 Accrued expenses and other liabilities 11,532,101 14,624,757 Convertible notes - 13,377,505 Current portion of long- term debt - 4,000,000 --------- --------- Total current liabilities 13,466,220 35,873,133 Other long-term liabilities 452,618 626,581 Derivative instruments 835,299 Convertible notes and other debt, net of discount of $2,705,440 in 2009 17,426,513 928,117 ---------- ------- Total liabilities 32,180,650 37,427,831 ---------- ---------- Stockholders' equity: Common stock, $0.0001 par value; 100,000,000 shares authorized; 28,130,284 and 25,890,143 shares issued and outstanding at December 31, 2009 and 2008 2,813 2,589 Additional paid-in- capital 157,004,037 142,392,163
'/>"/>
SOURCE PharmAthene, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. PharmAthene to Provide Update on SparVax(TM) Contract Modification Suspension During Year-End 2009 Financial and Operational Results Conference Call on Tuesday March 23, 2010
2. PharmAthene to Host Year-End 2009 Earnings Conference Call and Webcast on Tuesday, March 23, 2010
3. PharmAthene to Present at the 2010 Roth Capital Markets Growth Stock Conference on Monday, March 15, 2010
4. PharmAthene Submits White Paper to BARDA for Advanced Development Funding for SparVax(TM) - Novel Recombinant Protective Antigen Anthrax Vaccine
5. PharmAthene Appoints Jeffrey W. Runge, M.D. to the Companys Board of Directors
6. PharmAthene Announces Updated Time for Conference Call to Review BARDA rPA Decision
7. PharmAthene Reports Third Quarter 2009 Financial and Operational Results
8. PharmAthene Executives Featured in Anthrax Pathogen Training Video for U.S. Department of Homeland Security
9. PharmAthene Presents Data for Valortim(R) Anthrax Anti-Toxin and Third Generation rPA Anthrax Vaccine Programs at the Bacillus - ACT 2009 Conference
10. PharmAthene to Present at the Rodman and Renshaw Annual Global Investment Conference September 10, 2009
11. PharmAthene Reports Second Quarter 2009 Financial and Operational Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2014)... FREDERICK, Md. , Aug. 18, 2014 ... the maker of advanced consumer medical devices ... Kotak was interviewed by CEOLIVE.TV as ... The entire interview is available at ... interview Dr. Kotak explains to investors the ...
(Date:8/18/2014)... 2014 Global HIV Infection Drug Market ... by Reportstack. The rate of HIV infection and the number ... note at a positive rate across the globe. It has ... in 2005 to 1.5 in 2013, with the rates for ... drastic changes in the infection rates has been the improved ...
(Date:8/18/2014)... Fla. , Aug. 18, 2014 TNI ... biotechnology company pioneering the manufacturing and marketing of innovative ... that the Company is providing a second notice of ... In making the announcement, Noreen Griffin , ... you in advance for your participation in the Annual ...
(Date:8/18/2014)... August 2014 Vier führende deutsche ... klinische Studie auf, in der eine Intraokularlinse ... das Sehvermögen bei allen Entfernungen verbessern, so ... keine Lese- oder Gleitsichtbrille mehr benötigen. Die ... FluidVision Accommodating Intraocular Lens (FluidVision akkomodative ...
Breaking Biology Technology:BioElectronics EVP Dr. Deepak Kotak Interviewed on CEO Live 2BioElectronics EVP Dr. Deepak Kotak Interviewed on CEO Live 3Global HIV Infection Drug Market Overview 2Global HIV Infection Drug Market Overview 3Global HIV Infection Drug Market Overview 4TNI BioTech Inc., provides 2nd Notice of Annual Meeting September 4, 2014 2TNI BioTech Inc., provides 2nd Notice of Annual Meeting September 4, 2014 3TNI BioTech Inc., provides 2nd Notice of Annual Meeting September 4, 2014 4Implantation einer revolutionären akkommodativen Linse bei Katarakt-Patienten in deutschen Augenzentren im Rahmen einer internationalen klinischen Studie 2Implantation einer revolutionären akkommodativen Linse bei Katarakt-Patienten in deutschen Augenzentren im Rahmen einer internationalen klinischen Studie 3Implantation einer revolutionären akkommodativen Linse bei Katarakt-Patienten in deutschen Augenzentren im Rahmen einer internationalen klinischen Studie 4
... requires proper wound closure to ensure timely healing and ... received a $100,000 federal grant to develop alternatives to ... develops tissue repair products and advanced coatings for implanted ... Innovation Research grant. , ,The peer-reviewed grant, which ...
... athlete only three years ago, but his Milwaukee-based mobile software ... opening in 1996. , ,And now, the route of ... Asia. , ,Psuik, founder and owner of Developer ... with O2 , a European mobile phone provider, to ...
... Madison, Wis. - Now that two companies he ... another exit strategy, Brian Wiegand's days as a self-described ... the Madison-based NameProtect , a developer of digital ... Service Co. of Wilmington, Del. , ,He will ...
Cached Biology Technology:Milwaukee software developer gains bottom line, loses waistline 2Milwaukee software developer gains bottom line, loses waistline 3Milwaukee software developer gains bottom line, loses waistline 4NameProtect sold, tech entrepreneur to focus on Jellyfish.com 2
(Date:8/19/2014)... New measurements from fish purchased at retail seafood ... to which mislabeling can expose consumers to unexpectedly ... Fishery stock "substitutions"which falsely present a fish of ... originare the most dangerous mislabeling offense, according to ... scientists. , "Accurate labeling of seafood is essential ...
(Date:8/19/2014)... a biomarker strongly associated with basal-like breast cancer, ... many types of chemotherapy. The biomarker, a protein ... therapeutics designed to treat this often deadly cancer. ... The Cancer Genome Atlas, molecular biologists Curt M. ... and bioinformatics techniques to detect patterns of gene ...
(Date:8/19/2014)... -- Scientists at the Houston Methodist Research Institute have ... cells using a pipette -- a common laboratory tool ... and preliminary test results in a recent issue of ... , "Studying single cells and their unique functions has ... department. faculty member Lidong Qin, Ph.D., the project,s principal ...
Breaking Biology News(10 mins):Seafood substitutions can expose consumers to unexpectedly high mercury 2Seafood substitutions can expose consumers to unexpectedly high mercury 3Biomarker in an aggressive breast cancer is identified 2Biomarker in an aggressive breast cancer is identified 3Moving single cells around -- accurately and cheaply 2
... takes on special significance when scientists and students gather. ... success and survival with bright colors, flash and iridescence ... and materials scientists will delve into whats behind all ... held Feb. 6-9 at Arizona State University in Tempe, ...
... in the Earth,s oceans consume 90 percent of the ... ice preventing large amounts of methane from reaching ... microbes that accomplish this feat do not simply reverse ... compound instead. "The dominant role anaerobic oxidation of ...
... grants have been awarded to Public Health faculty at Weill ... Kenneth W. Griffin is the recipient of a three-year $1.6 ... (NIDA) for research into the long-term effects of a school-based ... New York City middle schools. The study will focus on ...
Cached Biology News:Iridescence workshop promotes nature's nanotechnology 2Paired microbes eliminate methane using sulfur pathway 22 federal public health grants awarded to Weill Cornell Medical College 2
...
... Kit has been designed for recovery of DNA from ... Features Ultra fast protocol: DNA is ready ... are easy to resuspend Bead uniformity prevents shearing ... (suitable for PCR) DNA is eluted into sterile ...
... BAS-2500 is ideal for ... Biology (1D electrophoresis, 2D ... Macroarrays); Pharmacokinetics & Toxicology ... layer chromatography); Physical and ...
... microscope is described by end-users to be ... the fundamentals of light microscopy and electronic ... footprint, it does not require much space ... busy lab environment. The DM-BA300 combines Motic's ...
Biology Products: